<?xml version='1.0' encoding='utf-8'?>
<document id="2611942"><sentence text="Binding of sulfonamides to erythrocyte proteins and possible drug-drug interaction."><entity charOffset="11-23" id="DDI-PubMed.2611942.s1.e0" text="sulfonamides" /></sentence><sentence text="The mode of binding of sulfonamides to erythrocyte proteins and possible drug-drug interaction between those compounds in erythrocytes resulting in changes in tissue levels were studied in rats using zonisamide (a novel antiepileptic agent possessing a sulfonamide group), several other sulfonamides and some antiepileptics without a sulfonamide group"><entity charOffset="23-35" id="DDI-PubMed.2611942.s2.e0" text="sulfonamides" /><entity charOffset="200-210" id="DDI-PubMed.2611942.s2.e1" text="zonisamide" /><entity charOffset="253-264" id="DDI-PubMed.2611942.s2.e2" text="sulfonamide" /><entity charOffset="287-299" id="DDI-PubMed.2611942.s2.e3" text="sulfonamides" /><entity charOffset="334-345" id="DDI-PubMed.2611942.s2.e4" text="sulfonamide" /><pair ddi="false" e1="DDI-PubMed.2611942.s2.e0" e2="DDI-PubMed.2611942.s2.e0" /><pair ddi="false" e1="DDI-PubMed.2611942.s2.e0" e2="DDI-PubMed.2611942.s2.e1" /><pair ddi="false" e1="DDI-PubMed.2611942.s2.e0" e2="DDI-PubMed.2611942.s2.e2" /><pair ddi="false" e1="DDI-PubMed.2611942.s2.e0" e2="DDI-PubMed.2611942.s2.e3" /><pair ddi="false" e1="DDI-PubMed.2611942.s2.e0" e2="DDI-PubMed.2611942.s2.e4" /><pair ddi="false" e1="DDI-PubMed.2611942.s2.e1" e2="DDI-PubMed.2611942.s2.e1" /><pair ddi="false" e1="DDI-PubMed.2611942.s2.e1" e2="DDI-PubMed.2611942.s2.e2" /><pair ddi="false" e1="DDI-PubMed.2611942.s2.e1" e2="DDI-PubMed.2611942.s2.e3" /><pair ddi="false" e1="DDI-PubMed.2611942.s2.e1" e2="DDI-PubMed.2611942.s2.e4" /><pair ddi="false" e1="DDI-PubMed.2611942.s2.e2" e2="DDI-PubMed.2611942.s2.e2" /><pair ddi="false" e1="DDI-PubMed.2611942.s2.e2" e2="DDI-PubMed.2611942.s2.e3" /><pair ddi="false" e1="DDI-PubMed.2611942.s2.e2" e2="DDI-PubMed.2611942.s2.e4" /><pair ddi="false" e1="DDI-PubMed.2611942.s2.e3" e2="DDI-PubMed.2611942.s2.e3" /><pair ddi="false" e1="DDI-PubMed.2611942.s2.e3" e2="DDI-PubMed.2611942.s2.e4" /></sentence><sentence text=" In Michaelis-Menten plottings, the sulfonamide was found to be concentrated into erythrocytes in vitro and in vivo in a saturable high-affinity mode and in a linear low-affinity mode at ordinary therapeutic plasma levels through a simple diffusion process"><entity charOffset="36-47" id="DDI-PubMed.2611942.s3.e0" text="sulfonamide" /></sentence><sentence text=" Concentration in erythrocytes was affected by the presence of albumin in the extracellular medium" /><sentence text=" The cellular sulfonamide was readily replaced by extracellular sulfonamides in vitro"><entity charOffset="14-25" id="DDI-PubMed.2611942.s5.e0" text="sulfonamide" /><entity charOffset="64-76" id="DDI-PubMed.2611942.s5.e1" text="sulfonamides" /><pair ddi="false" e1="DDI-PubMed.2611942.s5.e0" e2="DDI-PubMed.2611942.s5.e0" /><pair ddi="false" e1="DDI-PubMed.2611942.s5.e0" e2="DDI-PubMed.2611942.s5.e1" /></sentence><sentence text=" Even in vivo, erythrocyte levels of zonisamide were lowered by administration of other sulfonamides, although the plasma and tissue levels were not significantly changed since the plasma and tissue compartments of zonisamide were large relative to the erythrocyte compartment at ordinary therapeutic dose levels of zonisamide in animals and man"><entity charOffset="37-47" id="DDI-PubMed.2611942.s6.e0" text="zonisamide" /><entity charOffset="88-100" id="DDI-PubMed.2611942.s6.e1" text="sulfonamides" /><entity charOffset="215-225" id="DDI-PubMed.2611942.s6.e2" text="zonisamide" /><entity charOffset="316-326" id="DDI-PubMed.2611942.s6.e3" text="zonisamide" /><pair ddi="false" e1="DDI-PubMed.2611942.s6.e0" e2="DDI-PubMed.2611942.s6.e0" /><pair ddi="false" e1="DDI-PubMed.2611942.s6.e0" e2="DDI-PubMed.2611942.s6.e1" /><pair ddi="false" e1="DDI-PubMed.2611942.s6.e0" e2="DDI-PubMed.2611942.s6.e2" /><pair ddi="false" e1="DDI-PubMed.2611942.s6.e0" e2="DDI-PubMed.2611942.s6.e3" /><pair ddi="false" e1="DDI-PubMed.2611942.s6.e1" e2="DDI-PubMed.2611942.s6.e1" /><pair ddi="false" e1="DDI-PubMed.2611942.s6.e1" e2="DDI-PubMed.2611942.s6.e2" /><pair ddi="false" e1="DDI-PubMed.2611942.s6.e1" e2="DDI-PubMed.2611942.s6.e3" /><pair ddi="false" e1="DDI-PubMed.2611942.s6.e2" e2="DDI-PubMed.2611942.s6.e2" /><pair ddi="false" e1="DDI-PubMed.2611942.s6.e2" e2="DDI-PubMed.2611942.s6.e3" /></sentence><sentence text=" Therefore, disposition of zonisamide was not significantly influenced by other sulfonamides, but it is suggested that drug-drug interaction affecting the tissue levels may occur for a combination of sulfonamides with extremely different affinities for erythrocytes and low therapeutic plasma levels"><entity charOffset="27-37" id="DDI-PubMed.2611942.s7.e0" text="zonisamide" /><entity charOffset="80-92" id="DDI-PubMed.2611942.s7.e1" text="sulfonamides" /><entity charOffset="200-212" id="DDI-PubMed.2611942.s7.e2" text="sulfonamides" /><pair ddi="false" e1="DDI-PubMed.2611942.s7.e0" e2="DDI-PubMed.2611942.s7.e0" /><pair ddi="false" e1="DDI-PubMed.2611942.s7.e0" e2="DDI-PubMed.2611942.s7.e1" /><pair ddi="false" e1="DDI-PubMed.2611942.s7.e0" e2="DDI-PubMed.2611942.s7.e2" /><pair ddi="false" e1="DDI-PubMed.2611942.s7.e1" e2="DDI-PubMed.2611942.s7.e1" /><pair ddi="false" e1="DDI-PubMed.2611942.s7.e1" e2="DDI-PubMed.2611942.s7.e2" /></sentence><sentence text="" /></document>